Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,397 filings

Top spenders & firms Spend by issue

Clear
Q3
THE OUTLAW GROUP for SENTRY DATA SYSTEMS
3rd Quarter (July 1 - Sep 30) 2025 · Florida · House · $30,000.00 income
Health Issues, Pharmacy
View →
4A
KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Taxation/Internal Revenue Code, Defense, Health Issues, Medicare/Medicaid
View →
4A
THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Defense, Pharmacy
View →
4T
LMH STRATEGIC SOLUTIONS for NEUROCRINE BIOSCIENCES, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
4T
LMH STRATEGIC SOLUTIONS for BIOMARIN PHARMACEUTICAL, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
4T
LMH STRATEGIC SOLUTIONS for EXELIXIS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
4T
LMH STRATEGIC SOLUTIONS for ACADIA PHARMACEUTICALS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q4
TODD STRATEGY GROUP for PFIZER INC.
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)
View →
Q3
TODD STRATEGY GROUP for PFIZER INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)
View →
Q2
TODD STRATEGY GROUP for PFIZER INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $20,000.00 income
Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)
View →
RA
TODD STRATEGY GROUP for PFIZER INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia
Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)
View →
4A
BRIGHTSPRING HEALTH SERVICES for BRIGHTSPRING HEALTH SERVICES
4th Quarter (Oct 1 - Dec 31) 2025 · Kentucky · House · Senate
Medicare/Medicaid, Pharmacy
View →
3A
BRIGHTSPRING HEALTH SERVICES for BRIGHTSPRING HEALTH SERVICES
3rd Quarter (July 1 - Sep 30) 2025 · Kentucky · House · Senate
Medicare/Medicaid, Pharmacy
View →
2A
BRIGHTSPRING HEALTH SERVICES for BRIGHTSPRING HEALTH SERVICES
2nd Quarter (Apr 1 - June 30) 2025 · Kentucky · House · Senate
Medicare/Medicaid, Pharmacy
View →
1A
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy
View →
4A
KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Defense
View →
4A
PENN AVENUE PARTNERS for UNITEDHEALTH GROUP, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
3A
PENN AVENUE PARTNERS for UNITEDHEALTH GROUP, INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
2A
PENN AVENUE PARTNERS for UNITEDHEALTH GROUP, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
1A
PENN AVENUE PARTNERS for UNITEDHEALTH GROUP, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q4
THE HEALTH EQUITY STRATEGIES GROUP, LLC for TRAVERE THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · $16,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy
View →
Q4
MR. DAN CRIPPEN for AMGEN
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $100,000.00 income
Pharmacy, Economics/Economic Development, Government Issues
View →
Q4
RAY ANDERSON for 340B HEALTH
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House
Pharmacy, Health Issues, Medicare/Medicaid
View →
Q4
H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE for H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE
4th Quarter (Oct 1 - Dec 31) 2025 · Florida · House · Senate
Health Issues, Budget/Appropriations, Economics/Economic Development, Pharmacy
View →
Q4
POWERS PYLES SUTTER & VERVILLE, P.C. for NATIONAL ASSOCIATION OF SPECIALTY PHARMACY
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $120,000.00 income
Medicare/Medicaid, Pharmacy, Health Issues
View →
Page 1 of 56 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem